Viral Vector API Characterization of Product-Related Impurities

Author(s)Peter Wunderli, Jun Lu, Jie Ding

FDA’s final CMC guidance sets expectations for manufacturing and quality for human gene therapy INDs. This article reviews existing analytical applications, focusing on viral vector characterization of impurities.

In January 2020, the FDA issued Final Guidance for Industry: Chemistry Manufacturing and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs) and other guidance documents for human gene therapies, which set expectations for manufacturing and demonstration of quality (1). These products are applied to deliver genetic material (transgenes) or modified cells that have been designed to alleviate or even eliminate a broad range of diseases that are rooted in the genetics of individuals or populations of patients.

Read this article in BioPharm International’s Regulatory Sourcebook October 2020 eBook.

Article Details

BioPharm International
eBook: Regulatory Sourcebook, October 2020
October 2020
Pages: 12–17

Citation

When referring to this article, please cite it as P. Wunderli et al.,“Viral Vector API Characterization of Product-Related Impurities," BioPharm International Regulatory Sourcebook eBook (October 2020).

Articles in this issue

almost 5 years ago

Article

Bio/Pharma Industry Works Overtime to Find COVID-19 Therapies

almost 5 years ago

Article

GMPs Guide COVID-19 Vaccine Manufacturing

almost 5 years ago

Article

Do Pharmacopoeias Inadvertently Facilitate Data Integrity Violations?

almost 5 years ago

Article

Tackling Cybersecurity Challenges in Legacy Systems

almost 5 years ago

Article

Enhancing Process Validation for Sterile Liquid and Freeze-Dried Forms

almost 5 years ago

Article

Due Diligence Assessment of CMC Activities

almost 5 years ago

Article

Viewpoint: Precompetitive Collaboration Drives Pharma Industry Innovation

almost 5 years ago

Article

Strong Quality Culture: A How-To for Busy Managers

almost 5 years ago

Article

Resources, Guidelines, and Guidance Documents

almost 5 years ago

Article

Regulatory and Standard Setting Organizations

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!